[Number of chromosome aberrations induced by chemical carcinogens in the cells of patients with 2 forms of xeroderma pigmentosum].
A study was made of the effects of a chemical mutagen of the "gamma-type"--methylmethansulfonate (MMS) and of mutagen of the "UV-type"--4-nitroquinolin-1-oxide (NQO) and 7-brommethylbenz(alpha)antracen (BMBA) exerted on chromosome aberration frequency in lymphocytes of patients with classical Xeroderma pigmentosum and with a so-called form II of the disease on different stages of the cell cycle. Mutagens were added to PHA stimulated lymphocyte cultures every 3 hours, simultaneously with pulse 3H-thymidine labelling, to fix the stage of the cell cycle at the moment of treatment. NQO and BMBA treatments were found to increase the frequency of chromosome aberrations in classical XP cells, whereas MMS was not found to. In the XP II cells, defective in repair of both UV and gamma damaged DNA, chromosome aberrations yield is higher than in normal cells after all the three mutagens treatment. The data obtained show the correlation between DNA repair and chromosome aberrations yield.
D015112:4-Nitroquinoline-1-oxide / Q000633:toxicity; D001551:Benz(a)Anthracenes / Q000633:toxicity; D002273:Carcinogens; D002453:Cell Cycle; D002869:Chromosome Aberrations; D006801:Humans; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects*; D008741:Methyl Methanesulfonate / Q000633:toxicity; D009153:Mutagens; D014983:Xeroderma Pigmentosum / Q000097:blood*
D001551:Benz(a)Anthracenes; D002273:Carcinogens; D009153:Mutagens; C001903:7-bromomethylbenzanthracene; D015112:4-Nitroquinoline-1-oxide; D008741:Methyl Methanesulfonate
Chastota aberratsiĭ khromosom, vyzyvaemykh khimicheskimi kantserogenami v kletkakh dvumia formami pigmentonoĭ kserodermy.